Logo
K

KaliVir Immunotherapeutics

33 employees

KaliVir Immunotherapeutics develops oncolytic viral immunotherapy programs for the treatment of cancer.

Basic info

Industry

pharmaceutical manufacturing
biotechnology research

Sectors

Pharmaceutical
Therapeutics
Health Care

Date founded

2019

Funding rounds raised

K

KaliVir Immunotherapeutics raised undisclosed on March 16, 2022

Investors: Premier Partners, Company K Partners and QUAD Investment Management

FAQ